NeuroVive Pharmaceutical AB SMA 200
Cos'è SMA 200 di NeuroVive Pharmaceutical AB?
SMA 200 di NeuroVive Pharmaceutical AB è $0 -7.26%
Qual è la definizione di SMA 200?
SMA 200 è un prezzo medio delle azioni degli ultimi 200 giorni calcolato come media non ponderata dei precedenti 200 prezzi di chiusura delle scorte.
Simple moving average of 200 days for a stock is an unweighted moving average over the past 200 days. Moving averages will always exhibit a lag and the longer the period used for averaging the greater the lag will be. Because of the large amounts of data considered when calculating a long-term moving average, it takes a considerable amount of movement in the market to cause the moving average to change its course.
Using a moving average to confirm a trend in price is one of the most basic, yet effecting ways of using the indicator. Moving averages take into account what has already happened and a whole range of past events, which makes them such a good technical analysis tool for trend confirmations. Generally, a long-term moving average that is clearly on the upswing is a confirmation of a bullish trend. Conversely, a long-term moving average that is clearly on the downswing is a confirmation of a bearish trend.
SMA 200 di aziende nel Health Care settore su OTC rispetto a NeuroVive Pharmaceutical AB
Cosa fa NeuroVive Pharmaceutical AB?
Abliva AB (publ), a pharmaceutical company, engages in the research and development of mitochondrial medicine. The company is developing KL1333 that is in Phase I clinical trials for the chronic treatment of primary mitochondrial diseases; NV354, which is in the preparation for clinical trials for the treatment of primary mitochondrial diseases with Complex I deficiency; and NeuroSTAT for traumatic brain injury. It has collaboration agreements with Isomerase, Yungjin Pharm, University of Pennsylvania, Children's Hospital of Philadelphia, Patheon, and Oroboros Instruments. The company was formerly known as NeuroVive Pharmaceutical AB (publ) and changed its name to Abliva AB (publ) in May 2020. Abliva AB (publ) was incorporated in 2000 and is headquartered in Lund, Sweden.
Aziende con sma 200 simili a NeuroVive Pharmaceutical AB
- 8I ha SMA 200 di AUD$0 -29.63%
- Perk Labs ha SMA 200 di $0 +58.24%
- Latecoere S.A ha SMA 200 di €0 -43.93%
- BMG Resources ha SMA 200 di AUD$0 -52.24%
- Aspermont ha SMA 200 di AUD$0 -77.62%
- Athersys Inc ha SMA 200 di $0 +89.52%
- NeuroVive Pharmaceutical AB ha SMA 200 di $0 -7.26%
- Westar Resources ha SMA 200 di AUD$0 -53.36%
- Otto ha SMA 200 di AUD$0 +1.84%
- Celsius Resources ha SMA 200 di AUD$0 +1.74%
- Sunstone Metals ha SMA 200 di AUD$0 -80.15%
- O.A.T ha SMA 200 di $0 -170.37%
- Sultan Resources ha SMA 200 di AUD$0 -80.77%